v3.26.1
Segment and Geographic Information - Reconciliation to Income (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 28, 2026
Jun. 29, 2025
Jun. 28, 2026
Jun. 29, 2025
Segment Reporting [Line Items]        
Total revenues $ 630.9 $ 613.9 $ 1,250.7 $ 1,306.7
Segment Reporting, Reconciliation [Abstract]        
Cost of sales, excluding amortization of intangibles 271.4 256.1 540.7 536.0
Selling, marketing and administrative 99.6 97.1 205.5 196.2
Research and development 2.0 2.8 4.3 5.5
Other expense, net (2.1) (0.1) (2.1) 1.3
Total segment Adjusted EBITDA 260.0 258.0 502.3 567.7
Corporate (130.7) (151.2) (264.3) (301.1)
Depreciation and amortization (116.7) (110.3) (229.6) (217.4)
Interest expense, net (54.7) (40.5) (105.8) (80.5)
Restructuring, integration and other charges (6.5) (178.9) (10.9) (195.0)
Amortization of deferred cloud computing implementation costs (9.2) (6.8) (17.2) (11.1)
Employee compensation charges (4.5)   (10.0)  
Tax indemnification expense (3.3)   (3.3)  
EU medical device regulation transition costs (0.7) (0.1) (1.4) (0.3)
(Loss) gain on investments (8.1) 1.0 (9.0) 1.3
Other adjustments (6.8) (0.8) (11.5) (2.0)
Loss before income taxes (81.2) (229.6) (160.7) (238.4)
North America | Operating Segments        
Segment Reporting [Line Items]        
Total revenues 327.4 310.7 656.3 717.4
Segment Reporting, Reconciliation [Abstract]        
Cost of sales, excluding amortization of intangibles 116.7 110.6 231.2 239.0
Selling, marketing and administrative 40.7 40.0 85.1 83.6
Research and development 0.4 0.4 0.8 0.8
Other expense, net 0.0 0.0 0.2 0.0
Total segment Adjusted EBITDA 169.6 159.7 339.0 394.0
EMEA | Operating Segments        
Segment Reporting [Line Items]        
Total revenues 91.2 87.3 183.7 176.2
Segment Reporting, Reconciliation [Abstract]        
Cost of sales, excluding amortization of intangibles 44.3 43.9 88.9 91.2
Selling, marketing and administrative 23.9 23.6 50.5 46.5
Research and development 0.1 0.7 0.5 1.3
Other expense, net 0.8 0.8 1.6 2.4
Total segment Adjusted EBITDA 22.1 18.3 42.2 34.8
China | Operating Segments        
Segment Reporting [Line Items]        
Total revenues 67.8 83.4 131.3 158.4
Segment Reporting, Reconciliation [Abstract]        
Cost of sales, excluding amortization of intangibles 28.8 30.8 60.8 65.0
Selling, marketing and administrative 9.5 10.8 20.0 21.4
Research and development 0.6 0.8 1.3 1.7
Other expense, net (1.4) (1.1) (1.6) (1.1)
Total segment Adjusted EBITDA 30.3 42.1 50.8 71.4
JPAC | Operating Segments        
Segment Reporting [Line Items]        
Total revenues 74.3 72.2 144.3 140.3
Segment Reporting, Reconciliation [Abstract]        
Cost of sales, excluding amortization of intangibles 43.3 39.4 84.8 77.3
Selling, marketing and administrative 12.3 12.8 24.7 25.0
Research and development 0.3 0.4 0.6 0.8
Other expense, net 0.1 0.4 (0.6) 0.4
Total segment Adjusted EBITDA 18.3 19.2 34.8 36.8
Latin America | Operating Segments        
Segment Reporting [Line Items]        
Total revenues 70.2 60.3 135.1 114.4
Segment Reporting, Reconciliation [Abstract]        
Cost of sales, excluding amortization of intangibles 38.3 31.4 75.0 63.5
Selling, marketing and administrative 13.2 9.9 25.2 19.7
Research and development 0.6 0.5 1.1 0.9
Other expense, net (1.6) (0.2) (1.7) (0.4)
Total segment Adjusted EBITDA $ 19.7 $ 18.7 $ 35.5 $ 30.7